[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  @CencoraGlobal Cencora Cencora posts on X about cencora, pharma, vivo the most. They currently have XXXXX followers and XXX posts still getting attention that total X engagements in the last XX hours. ### Engagements: X [#](/creator/twitter::288863891/interactions)  - X Week XXX +131% - X Month XXXXX +689% - X Months XXXXX -XX% - X Year XXXXXX -XX% ### Mentions: X [#](/creator/twitter::288863891/posts_active)  - X Week X +50% - X Month XX +43% - X Months XX -XX% - X Year XXX -XX% ### Followers: XXXXX [#](/creator/twitter::288863891/followers)  - X Week XXXXX +0.05% - X Month XXXXX +0.31% - X Months XXXXX +1.50% - X Year XXXXX +0.68% ### CreatorRank: undefined [#](/creator/twitter::288863891/influencer_rank)  ### Social Influence [#](/creator/twitter::288863891/influence) --- **Social category influence** [stocks](/list/stocks) [finance](/list/finance) [technology brands](/list/technology-brands) **Social topic influence** [cencora](/topic/cencora) #26, [pharma](/topic/pharma), [vivo](/topic/vivo) **Top assets mentioned** [Cencora, Inc. (COR)](/topic/cencora) ### Top Social Posts [#](/creator/twitter::288863891/posts) --- Top posts by engagements in the last XX hours "Cell and gene therapy breakthroughs require a well-planned path to market. Cencora VP Kevin Chinn shares why early and integrated planning is key to avoiding regulatory access and logistics hurdles in @PharmaCommerce:" [X Link](https://x.com/CencoraGlobal/status/1955294507144007939) [@CencoraGlobal](/creator/x/CencoraGlobal) 2025-08-12T15:45Z 6114 followers, XXX engagements "In her @PharmaCommerce video interview series Heather Zenk President of U.S. Supply Chain at Cencora shares insights on building a more resilient and efficient pharmaceutical supply chain. Watch the full series here:" [X Link](https://x.com/CencoraGlobal/status/1960754240592232684) [@CencoraGlobal](/creator/x/CencoraGlobal) 2025-08-27T17:20Z 6114 followers, XXX engagements "John Arena President of Global Pharma Services shares why accelerated regulatory pathways demand accelerated readinessplus insights on payer engagement global planning and commercialization strategy on In Vivo Citeline. Learn more:" [X Link](https://x.com/CencoraGlobal/status/1958602892669042770) [@CencoraGlobal](/creator/x/CencoraGlobal) 2025-08-21T18:51Z 6115 followers, XXX engagements "Expanding access to healthcare starts with reducing barriers to treatment especially for specialty medications. In @SpecialtyPharm Chara Reid and Christie Smith point to approaches like medically integrated dispensing to improve coordination and patient access:" [X Link](https://x.com/CencoraGlobal/status/1970561084416311670) [@CencoraGlobal](/creator/x/CencoraGlobal) 2025-09-23T18:49Z 6115 followers, XXX engagements "As of August XX most distributors successfully met the enhanced tracing requirements under the Drug Supply Chain Security Act (DSCSA)a major step forward in securing the pharmaceutical supply chain. Read more on Regulatory Focus:" [X Link](https://x.com/CencoraGlobal/status/1973104358091870474) [@CencoraGlobal](/creator/x/CencoraGlobal) 2025-09-30T19:15Z 6115 followers, XXX engagements "IntrinsiQ Specialty Solutions is expanding its data and insights to support precision medicine providing manufacturers with real-world visibility into therapy use. See how this strengthens connections across the healthcare ecosystem:" [X Link](https://x.com/CencoraGlobal/status/1978896527549452365) [@CencoraGlobal](/creator/x/CencoraGlobal) 2025-10-16T18:51Z 6115 followers, XXX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Cencora posts on X about cencora, pharma, vivo the most. They currently have XXXXX followers and XXX posts still getting attention that total X engagements in the last XX hours.
Social category influence stocks finance technology brands
Social topic influence cencora #26, pharma, vivo
Top assets mentioned Cencora, Inc. (COR)
Top posts by engagements in the last XX hours
"Cell and gene therapy breakthroughs require a well-planned path to market. Cencora VP Kevin Chinn shares why early and integrated planning is key to avoiding regulatory access and logistics hurdles in @PharmaCommerce:"
X Link @CencoraGlobal 2025-08-12T15:45Z 6114 followers, XXX engagements
"In her @PharmaCommerce video interview series Heather Zenk President of U.S. Supply Chain at Cencora shares insights on building a more resilient and efficient pharmaceutical supply chain. Watch the full series here:"
X Link @CencoraGlobal 2025-08-27T17:20Z 6114 followers, XXX engagements
"John Arena President of Global Pharma Services shares why accelerated regulatory pathways demand accelerated readinessplus insights on payer engagement global planning and commercialization strategy on In Vivo Citeline. Learn more:"
X Link @CencoraGlobal 2025-08-21T18:51Z 6115 followers, XXX engagements
"Expanding access to healthcare starts with reducing barriers to treatment especially for specialty medications. In @SpecialtyPharm Chara Reid and Christie Smith point to approaches like medically integrated dispensing to improve coordination and patient access:"
X Link @CencoraGlobal 2025-09-23T18:49Z 6115 followers, XXX engagements
"As of August XX most distributors successfully met the enhanced tracing requirements under the Drug Supply Chain Security Act (DSCSA)a major step forward in securing the pharmaceutical supply chain. Read more on Regulatory Focus:"
X Link @CencoraGlobal 2025-09-30T19:15Z 6115 followers, XXX engagements
"IntrinsiQ Specialty Solutions is expanding its data and insights to support precision medicine providing manufacturers with real-world visibility into therapy use. See how this strengthens connections across the healthcare ecosystem:"
X Link @CencoraGlobal 2025-10-16T18:51Z 6115 followers, XXX engagements
/creator/twitter::CencoraGlobal